BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 371382)

  • 1. Bacteriocin typing of Serratia marcescens. A simplified system.
    Sproat D; Brown A
    Am J Clin Pathol; 1979 Feb; 71(2):172-6. PubMed ID: 371382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriocin (marcescin) typing of clinically isolated Serratia marcescens.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):33-43. PubMed ID: 7015560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epidemiological study of Serratia marcescens infections by bacteriocin typing.
    Nasu M; Goto J; Goto I
    Microbiol Immunol; 1982; 26(9):795-801. PubMed ID: 6759881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distribution of clinical isolates of Serratia marcescens by bacteriocin typing: a comparison of bacteriocin types between two distant university hospitals].
    Nasu M; Goto J; Goto Y; Tashiro T; Itoga T; Yamaguchi K
    Kansenshogaku Zasshi; 1984 Apr; 58(4):312-7. PubMed ID: 6434655
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):218-25. PubMed ID: 4552884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological studies of Serratia marcescens infections by bacteriocin (marcescin) typing.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):45-52. PubMed ID: 7015561
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens.
    Traub WH; Raymond EA; Startsman TS
    Appl Microbiol; 1971 May; 21(5):837-40. PubMed ID: 4930037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin sensitivity.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):226-31. PubMed ID: 4552885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriocin typing of Serratia marcescens isolates of known serotype-group.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):979-81. PubMed ID: 4555640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens.
    Alonso R; Aucken HM; Perez-Diaz JC; Cookson BD; Baquero F; Pitt TL
    Epidemiol Infect; 1993 Aug; 111(1):99-107. PubMed ID: 8102336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):982-5. PubMed ID: 4555641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacteriocin (marcescin) typing of Serratia marcescens. II. The distribution of Serratia marcescens in hospital and its isolated cases by bacteriocin (marcescin) typing (author's transl)].
    Nasu M
    Kansenshogaku Zasshi; 1978 Jun; 52(6):183-9. PubMed ID: 101627
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacteriocin typing and biotyping of clinical isolates of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol; 1991 Oct; 275(4):474-86. PubMed ID: 1755921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endemic Serratia marcescens in the Veterans Administration Hospital in Pittsburgh, Pa., 1971--1976.
    Brown A; Davis L; Yee RB; Postic B
    Health Lab Sci; 1978 Jul; 15(3):159-67. PubMed ID: 359506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].
    Minck R; Le Minor S; Pigache F; Dammron A; Reeb E; Kohen M; Le Faou A
    Pathol Biol (Paris); 1980 Oct; 28(8):501-7. PubMed ID: 7001322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.
    Traub WH; Raymond EA
    Appl Microbiol; 1971 Dec; 22(6):1058-63. PubMed ID: 4944804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation rate of non-hemagglutinating strains of Serratia marcescens from clinical specimens in a general hospital: comparison of serotypes O2 and O14.
    Yanagawa Y; Marumo K; Nakamura Y; Shimamura T
    J Infect Chemother; 2007 Jun; 13(3):151-6. PubMed ID: 17593501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serratia marcescens as an opportunistic human pathogen].
    Yokota M; Okazawa A; Tanaka T
    Nihon Saikingaku Zasshi; 2001; 56(3):527-35. PubMed ID: 11577410
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenotypic variation of clinical Serratia marcescens isolates repeatedly recovered from individual patients.
    Traub WH; Eiden A; Leonhard B; Bauer D
    Zentralbl Bakteriol; 1996 Jun; 284(1):124-35. PubMed ID: 8837376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods for differentiating among Serratia marcescens isolated from clinical specimens.
    Roemisch E; Kocka FE
    Am J Clin Pathol; 1976 Jul; 66(1):96-100. PubMed ID: 779447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.